-
ICPerMed State of the Art Report 2018
14 November 2019 – The ICPerMed State of the Art Report 2018 has now been published. The report resumes ICPerMed activities performed in the second year since the establishment of the consortium: November 2017 to October 2018.
-
ICPerMed Workshop 2019: ‘Personalised Medicine for All Citizens and Patients within Sustainable Implementation’
12 November 2019 – The second workshop ‘Personalised Medicine for All Citizens and Patients within Sustainable Implementation’ of the International Consortium for Personalised Medicine (ICPerMed) assembled around 150 experts from 31 countries in Madrid, Spain.
-
Call Announcement: ICPerMed Recognition 2020
06 November 2019 – The International Consortium for Personalised Medicine (ICPerMed) has published the announcement for their third ‘Best Practice in Personalised Medicine’ Recognition 2020 today. The objective of this recognition is to honour, encourage, promote and disseminate outstanding best practice examples in personalised medicine.
-
Pre-announcement: ERA PerMed Call 2020
5 November 2019 – ERA PerMed will launch the third Joint Transnational Call for Proposals to support translational research projects in the field of Personalised Medicine in December 2019.
-
ICPerMed ‘Best Practice in Personalised Medicine’ Recognition 2020
7 October 2019 – The International Consortium for Personalised Medicine (ICPerMed) has published the pre-announcement for their third ‘Best Practice in Personalised Medicine’ Recognition 2020 today. The objective of this recognition is to honour, encourage, promote and disseminate outstanding best practice examples in personalised medicine.
-
ICPerMed Vision Paper: How can personalised approaches pave the way to next-generation medicine?
25 September 2019 – ICPerMed published a “Vision Paper” on how the use of personalised medicine approaches will promote “next-generation” medicine in 2030. The vision entails that medicine needs to become more firmly centred on the individual’s personal characteristics and at the same time be more effective and have an economic value. Next-generation medicine should…
-
NOS-M Report “Personalised Medicine in the Nordic Countries” published
13 September 2019 – The Joint Committee of the Nordic Medical Research Councils (NOS-M) published its new report “Personalised Medicine in the Nordic Countries”.
-
Workshop “Organizing and maximizing rare disease biological sample data in biobanks”, 29-30 October 2019, Vilnius, Lithuania
9 September 2019 – On 29-30 October 2019, a training workshop on “Organizing and maximizing rare disease biological sample data in biobanks” will take place in Vilnius, Lithuania. This workshop is a part of a series of capacity building programs put forth by the European Joint Programme on Rare Diseases (EJP RD).
-
International Conference on Rare Diseases and Orphan Drugs on 11-13 November 2019 in Israel
2 September 2019 – The 14th Meeting of the International Conference on Rare Diseases and Orphan Drugs (ICORD) “Rare Diseases Are Not Orphans” will take place from 11 to 13 November 2019 in Rishon-Lezion, Israel.
-
Start of four ICPerMed-related coordination and support actions
19 June 2019 – Through its Framework Programme Horizon 2020, the European Union started funding four actions in support of ICPerMed in 2019. All four actions focus on different aspects of personalised medicine.
